[Neuromediators in dermatology. Therapeutic prospectives].
Neuropeptides are neurotransmitters and neurohormones that play a role in various cutaneous functions. Keratinocytes and dermal endothelial cells are able to synthesize neuropeptides which are transported by nerve fibers or immune cells. Specific receptors for neuropeptides are also present on cutaneous cells. Neuropeptides intervene as neurogenic modulators of inflammatory reactions and therefore participate in the pathogenesis of skin diseases. An increasing body of evidence supports the setting up of clinical trials using topically neuropeptide agonists and/or antagonists in the treatment of chronic inflammatory skin disorders such as post-herpetic neuralgia, prurigo nodularis, localized pruritus, psoriasis, atopic dermatitis, contact dermatitis, cold urticaria, nostalgia paresthetica, diabetic neuropathy, Raynaud's phenomenon. In the near future, neuropeptides will represent a new approach to skin therapy.
Claudy
A
A
Clinique Dermatologique, Hôpital Edouard Herriot, Lyon, France.
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D005544:Forecasting; D006801:Humans; D009479:Neuropeptides / Q000494:pharmacology* / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects*; D012871:Skin Diseases / Q000188:drug therapy; D015320:Tachykinins / Q000494:pharmacology / Q000627:therapeutic use; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D009479:Neuropeptides; D015320:Tachykinins; D014660:Vasoactive Intestinal Peptide; D015740:Calcitonin Gene-Related Peptide
Les neuromédiateurs en dermatologie perspectives thérapeutiques.